G
Giovanni B. Frisoni
Researcher at University of Geneva
Publications - 956
Citations - 55940
Giovanni B. Frisoni is an academic researcher from University of Geneva. The author has contributed to research in topics: Dementia & Medicine. The author has an hindex of 101, co-authored 871 publications receiving 46199 citations. Previous affiliations of Giovanni B. Frisoni include Geneva College & University of Rome Tor Vergata.
Papers
More filters
Journal ArticleDOI
Functional cortical source connectivity of resting state electroencephalographic alpha rhythms shows similar abnormalities in patients with mild cognitive impairment due to Alzheimer's and Parkinson's diseases.
Claudio Babiloni,Claudio Del Percio,Roberta Lizio,Giuseppe Noce,Susanna Lopez,Andrea Soricelli,Raffaele Ferri,Maria Teresa Pascarelli,Valentina Catania,Flavio Nobili,Dario Arnaldi,Francesco Famà,Francesco Orzi,Carla Buttinelli,Franco Giubilei,Laura Bonanni,Raffaella Franciotti,Marco Onofrj,Paola Stirpe,Peter Fuhr,Ute Gschwandtner,Gerhard Ransmayr,Heinrich Garn,Lucia Fraioli,Michela Pievani,Fabrizia D'Antonio,Carlo de Lena,Bahar Güntekin,Lutfu Hanoglu,Erol Başar,Görsev Yener,Derya Durusu Emek-Savaş,Antonio Ivano Triggiani,John-Paul Taylor,Maria Francesca De Pandis,Laura Vacca,Giovanni B. Frisoni,Fabrizio Stocchi +37 more
TL;DR: These findings unveil similar abnormalities in functional cortical connectivity estimated in widespread alpha sources in ADMCI and PDMCI, true at both group and individual levels.
Journal ArticleDOI
Factors related to length of stay in a Geriatric Evaluation and Rehabilitation Unit
TL;DR: The association of longer length of stay with greater comorbidity was enhanced by impairment in gait and balance (Tinetti <18) and malnutrition (PNI >45) and data suggest that the length ofStay in hospital is related to comorbbidity in patients with conditions of physical and biomedical frailty.
Journal ArticleDOI
Dementia imaging in clinical practice: a European-wide survey of 193 centres and conclusions by the ESNR working group.
Meike W. Vernooij,Francesca B. Pizzini,Reinhold Schmidt,Marion Smits,Tarek A. Yousry,Núria Bargalló,Giovanni B. Frisoni,Sven Haller,Sven Haller,Frederik Barkhof,Frederik Barkhof +10 more
TL;DR: Current practice in dementia imaging is fairly homogeneous across Europe, in terms of image acquisition and image interpretation, and hurdles identified include training on the use of visual rating scales, implementation of volumetric assessment and structured reporting.
Journal ArticleDOI
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
Liu Shi,Sarah Westwood,Alison L. Baird,Laura Winchester,Valerija Dobricic,Fabian Kilpert,Shengjun Hong,Andre Franke,Abdul Hye,Nicholas J. Ashton,Angharad R. Morgan,Isabelle Bos,Stephanie J. B. Vos,Noel J. Buckley,Mara ten Kate,Philip Scheltens,Rik Vandenberghe,Silvy Gabel,Karen Meersmans,Sebastiaan Engelborghs,Ellen Elisa De Roeck,Ellen Elisa De Roeck,Kristel Sleegers,Giovanni B. Frisoni,Olivier Blin,Jill C. Richardson,Régis Bordet,José Luis Molinuevo,Lorena Rami,Anders Wallin,Petronella Kettunen,Petronella Kettunen,Magda Tsolaki,Frans R.J. Verhey,Alberto Lleó,Daniel Alcolea,Julius Popp,Julius Popp,Gwendoline Peyratout,Pablo Martinez-Lage,Mikel Tainta,Peter Johannsen,Charlotte E. Teunissen,Yvonne Freund-Levi,Yvonne Freund-Levi,Yvonne Freund-Levi,Lutz Frölich,Cristina Legido-Quigley,Cristina Legido-Quigley,Frederik Barkhof,Kaj Blennow,Kaj Blennow,Henrik Zetterberg,Susan Baker,B. Paul Morgan,Johannes Streffer,Johannes Streffer,Pieter Jelle Visser,Pieter Jelle Visser,Pieter Jelle Visser,Lars Bertram,Lars Bertram,Simon Lovestone,Alejo J. Nevado-Holgado +63 more
TL;DR: Plasma proteins have been widely studied as candidate biomarkers to predict brain amyloid deposition to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease but most studies are targeted to specific proteins or are biased toward high abundant proteins.
Journal ArticleDOI
Corticobasal degeneration: neuropsychological assessment and dopamine D2 receptor SPECT analysis.
Giovanni B. Frisoni,Gilberto Pizzolato,Orazio Zanetti,Angelo Bianchetti,Franca Chierichetti,Marco Trabucchi +5 more
TL;DR: It is suggested that a postsynaptic lesion in the basal ganglia might account for the lack of response of extrapyramidal motor symptoms to dopaminergic agonists in corticobasal degeneration.